pensyarah universiti
pusat kajian diagnostik, teraputik & penyiasatan (codtis)
nurulamin@ukm.edu.my
Kluster Kepakaran/ Cluster of Expertise :
Kesihatan dan Perubatan Termaju,
Biografi/ Biography :
I am a Senior Lecturer (Biomedical Science Program) & Researcher (CODTIS) at the Faculty of Health Sciences, UKM. My research focuses on discovering novel biomarkers using mass spectrometry-based technologies in glycomics and glycoproteomics as well as immunoassay technology, particularly for congenital disorders of glycosylation (CDG) and glycosylation-related diseases like cancer. As a Medical Lab Scientist (MLS), I specialize in Quality Assurance (QA), Quality Control (QC), and managing specialized diagnostics in clinical biochemistry laboratory.
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
nurulamin abu bakar, nurul izzati hamzan, elyssa milus majawit, siti nurwani ahmad ridzuan, noor hafizah hassan, anasufiza habib, lock-hock ngu. (2025). multi-omics characterization of a novel ssr4 variant in congenital disorders of glycosylation. - metabolites. 1 - 12.
nurulamin abu bakar. (2025). long-term qc monitoring and determination of analytical performance specifications (aps) for risk-based qc implementation. - bengkel pengurusan risiko dalam kawalan mutu dalaman (qc) bagi makmal patologi kimia kkm. .
nurulamin abu bakar. (2025). penyelidikan biokimia klinikal di malaysia: apa yang boleh disumbangkan oleh ahli sains makmal perubatan?. - bengkel penyelidikan bidang kimia hayat kementerian kesihatan malaysia 2025. .
nurulamin abu bakar. (2025). risk management in biomedical laboratory: an introduction. - bengkel sinergi pengajaran dan pembelajaran program sains bioperubatan semester 2 sesi akademik 2024/2025. .
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
nurulamin abu bakar, nurul izzati hamzan, elyssa milus majawit, siti nurwani ahmad ridzuan, noor hafizah hassan, anasufiza habib, lock-hock ngu. (2025). multi-omics characterization of a novel ssr4 variant in congenital disorders of glycosylation. - metabolites. 1 - 12.
nurulamin abu bakar, and nurul izzati hamzan.. (2025). advancement in clinical glycomics and glycoproteomics for congenital disorders of glycosylation: progress and challenges ahead . - biomedicines. 1 - 18.
nurulamin abu bakar, nurul izzati hamzan, siti nurwani ahmad ridzuan, izatus shima taib, zariyantey abdul hamid, anasufiza habib, noor hafizah hassan. (2026). multi-marker evaluation of creatinine, cystatin c and ß2-microglobulin for gfr estimation in stage 3–4 ckd using the 2021 ckd-epi equations. - international journal of molecular sciences . 1 - 13.
nurulamin abu bakar, and nurul izzati hamzan.. (2025). advancement in clinical glycomics and glycoproteomics for congenital disorders of glycosylation: progress and challenges ahead . - biomedicines. 1 - 18.
nurulamin abu bakar, nurul izzati hamzan, elyssa milus majawit, siti nurwani ahmad ridzuan, noor hafizah hassan, anasufiza habib, lock-hock ngu. (2025). multi-omics characterization of a novel ssr4 variant in congenital disorders of glycosylation. - metabolites. 1 - 12.
nurulamin abu bakar. (2025). penyelidikan biokimia klinikal di malaysia: apa yang boleh disumbangkan oleh ahli sains makmal perubatan?. - bengkel penyelidikan bidang kimia hayat kementerian kesihatan malaysia 2025. .
nurulamin abu bakar. (2025). peranan ahli sains kesihatan dalam penjagaan kesihatan di malaysia. - program dari codtis ke asiqs: membina jejak keilmuan. .
nurulamin abu bakar. (2025). ms iso 15189:2022 and risk-based iqc – meeting the accreditation standard. - national pathology conference 2025. .
nurulamin abu bakar. (2025). long-term qc monitoring and determination of analytical performance specifications (aps) for risk-based qc implementation. - bengkel pengurusan risiko dalam kawalan mutu dalaman (qc) bagi makmal patologi kimia kkm. .
nurulamin abu bakar. (2025). penyelidikan biokimia klinikal di malaysia: apa yang boleh disumbangkan oleh ahli sains makmal perubatan?. - bengkel penyelidikan bidang kimia hayat kementerian kesihatan malaysia 2025. .
nurulamin abu bakar. (2025). risk management in biomedical laboratory: an introduction. - bengkel sinergi pengajaran dan pembelajaran program sains bioperubatan semester 2 sesi akademik 2024/2025. .
nurulamin abu bakar. (2025). peranan ahli sains kesihatan dalam penjagaan kesihatan di malaysia. - program dari codtis ke asiqs: membina jejak keilmuan. .
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Quality Assurance (QA) & Quality Control (QC) in Medical Laboratory
Pengalaman / Experience : 21 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Specialized Diagnostics in Chemical Pathology Laboratory
Pengalaman / Experience : 21 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Congenital Disorders of Glycosylation (CDG)
Pengalaman / Experience : 17 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Clinical Glycomics
Pengalaman / Experience : 12 tahun/years(s)
HEALTH SCIENCES :CLINICAL AND HEALTH SCIENCES
Biomarker Discovery by Omics and Bioinformatics
Pengalaman / Experience : 8 tahun/years(s)